Búsqueda avanzada
Noticias (20)
Empresas (1)
HAE IN CORPORATION es una empresa con sede en Corea que se dedica al suministro de equipo de construcción e ingeniería civil. La empresa suministra equipos de construcción y pesados, como cargadores de ruedas, cargadores de orugas, excavadoras, bulldozers ...
Insiders
En la actualidad, Colette M. Kress ocupa el cargo de Directora Financiera y Vicepresidenta Ejecutiva de NVIDIA Corp. Anteriormente, la Sra. Kress fue vicepresidenta senior y directora financiera de tecnología empresarial y operaciones financieras en Cisco Systems, Inc. y directora financiera de la división de servidores y herramientas en Microsoft Corp. Se licenció en la Universidad de Arizona y obtuvo un MBA en la Southern Methodist University.
Cathann A.
Kress is currently the Chairman at W.K.
Kellogg Foundation.
She also holds positions as Vice President-Extension & Outreach at Iowa State University and Trustee at National 4-H Council, Inc. In terms of education, she completed her undergraduate degree at Iowa State University and her graduate and doctorate degrees at the University of Iowa.
Mr. Mark Kress is a Portfolio Manager at Security Investors LLC.
Prior to joining Security Investors, he was with Security Global Investor which is acquired by Security Investors.
William F.
Kress has held positions as Chairman, President & CEO at Green Bay Packaging, Inc. since 1995.
He is also currently a Director at The Green Bay Packers, Inc.
Viktor Melkhiorovich Kress is currently a Member of The Federation Council of The Fed Assembly of The Russian Fed.
Jean-Paul Kress is currently the CEO & Chairman-Management Board at MorphoSys AG since 2019 and the President & Director at Syntimmune, Inc. since 2018.
Previously, he served as the President & Chief Executive Officer at Sanofi Pasteur MSD SNC from 2011 to 2015.
He was also the Chairman at ERYTech Pharma SA from 2019 to 2023.
In addition, he held positions as an Independent Director at Sarepta Therapeutics, Inc. from 2015 to 2017, Director at Quantum Genomics SA from 2018 to 2019, President-International & Executive Vice President at Biogen, Inc. from 2017 to 2018, and Senior Vice President & Head-North America at Genzyme Corp.
from 2015 to 2017.
Dr. Kress obtained his undergraduate and graduate degrees from École Normale Supérieure in 1991 and his doctorate degree from Faculté De Médecine Necker Enfants Malades Université in 1991.
No hay resultados para esta búsqueda
- Bolsa de valores
- Búsqueda avanzada
- Colette Kress